TG Therapeutics, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2025: 2.44

TG Therapeutics, Inc. Interest Coverage Ratio is 2.44 for the Trailing 12 Months (TTM) ending March 31, 2025, a -45.22% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.
  • TG Therapeutics, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2024 was 4.45, a -128.82% change year over year.
  • TG Therapeutics, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2023 was -15.44, a -69.10% change year over year.
  • TG Therapeutics, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2022 was -49.98, a 12.62% change year over year.
  • TG Therapeutics, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2021 was -44.38, a 38.13% change year over year.
Key Data
Date Interest Coverage Ratio Return on Capital Employed (ROCE) Return on Equity (ROE) Return on Assets (ROA)